Posted: December 26, 2018 at 11:42 am

Enzyme can target almost half of the genomes ZIP codes and could enable editing of many more disease-specific mutations.

McGovern Institute scientist is recognized with award for outstanding and creative achievements made in the life and medical sciences.

Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.

A new daughter helped Alejandra Falla PhD 18 gain perspective on life and her tiny MIT regalia stole the show at Commencement.

Study reveals why people with the APOE4 gene have higher risk of the disease.

With SHERLOCK, a strip of paper can now indicate presence of pathogens, tumor DNA, or any genetic signature of interest.

Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.

Department of Biology kicks off IAP seminar series with a lecture by synthetic-biology visionary George Church.

New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.

REPAIR system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.

Biological engineers identify genes that protect against protein linked to Parkinsons disease.

MIT associate professor and member of the Broad Institute and McGovern Institute recognized for commitment to invention, collaboration, and mentorship.

Five recipients honored for their fundamental and complementary accomplishments related to CRISPR-Cas9.

Mark Bathe develops molecular packages for targeted delivery of drugs, vaccines, and gene-editing tools.

Red, green, and blue light can be used to control gene expression in engineered E. coli.

SDSCon 2017 gathers community and showcases research projects that apply data science to major systems and issues.

Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.

New system adapts tool known for gene editing; to be used in rapid, inexpensive disease diagnosis.

MIT professor and NAS report committee co-chair Richard Hynes gives insight into the reports recommendations.

Charles Jennings of MITs McGovern Institute discusses the intellectual property dispute over the gene-editing technique.

Original post:

Related Post

Comments are closed.